
Piramidal Inc. develops foundational AI technology focused on understanding brainwaves through EEG data. Their platform bridges the gap between neuroscience research and practical EEG applications in diagnostics and wellbeing. The company leverages deep learning and neuroengineering expertise to create software that analyzes microscale brain network dynamics, targeting neurological conditions such as epilepsy and dystonia. With a team led by experts from King's College London and St Thomas' Hospital, Piramidal aims to transform brainwave interpretation for clinical and health markets, positioning itself as a pioneer in AI-driven brain diagnostics.

Piramidal Inc. develops foundational AI technology focused on understanding brainwaves through EEG data. Their platform bridges the gap between neuroscience research and practical EEG applications in diagnostics and wellbeing. The company leverages deep learning and neuroengineering expertise to create software that analyzes microscale brain network dynamics, targeting neurological conditions such as epilepsy and dystonia. With a team led by experts from King's College London and St Thomas' Hospital, Piramidal aims to transform brainwave interpretation for clinical and health markets, positioning itself as a pioneer in AI-driven brain diagnostics.
Stage: Seed / Pre-seed (YC W24)
Focus: AI software for interpreting EEG / brainwave data
Founders: Dimitris Fotis Sakellariou; Kris Pahuja
Headquarters: San Francisco, CA
Reported funding: Seed / pre-seed; company site lists $6M; other records list $8M
Neurological diagnostics and EEG analysis
2024
Biotechnology
Announced pre-seed / seed funding round; company site lists a $6M seed figure while other records list total funding figures that vary.
“Investors include Y Combinator, Lionheart Ventures, Adverb VC, 10 BOND, CoreNest Capital, Futureland Ventures, Kahlil Lalji”